Type | Subsidiary |
Parent Company | Celgene |
HQ | Seattle, WA, US |
Founded | 2013 |
Website | junotherapeutics.com |
Cybersecurity rating | AMore |
Founding Date | 2013 |
Total Funding | $310 m |
Investors | Bezos Expeditions, Venrock, ARCH Venture Partners, Alaska Permanent Fund |
USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 12.5m | 1.6m | 9.8m | 27.6m | 20.8m | 19.3m | 21.3m | 44.8m | |
General and administrative expense | 6.7m | 14.9m | 13.6m | 16.0m | 16.8m | 18.4m | 20.7m | 23.6m | 26.3m |
R&D expense | 57.8m | 60.2m | 11.5m | 73.7m | 72.3m | 60.9m | 82.9m | 101.1m | 140.3m |
Operating expense total | 64.5m | 80.4m | 25.1m | 89.7m | 89.1m | 79.3m | 103.7m | 124.7m | 166.6m |
USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (65.0m) | (130.9m) | (154.2m) | (71.1m) | (135.9m) | (192.8m) | (82.2m) | (182.9m) | (301.1m) |
Depreciation and Amortization | 1.0m | 2.2m | 3.6m | 3.2m | 6.8m | 10.4m | 3.3m | 9.0m | 15.7m |
Accounts Payable | (27.0k) | 6.7m | 16.7m | (4.5m) | 7.9m | 8.6m | 28.0m | 40.0m | 45.2m |
Cash From Operating Activities | (21.6m) | (70.2m) | 49.9m | (58.2m) | (53.4m) | (120.4m) | (53.9m) | (91.9m) | (132.2m) |
USD | Q1, 2015 |
---|---|
Financial Leverage | 1.4 x |
FY, 2016 | |
---|---|
Patent Applications | 481 |
Patents (Foreign) | 86 |
Patents (US) | 72 |
A
78/100
A+
86/100
A+
91/100
When was Juno Therapeutics founded?
Juno Therapeutics was founded in 2013.
Who are Juno Therapeutics key executives?
Juno Therapeutics's key executives are Hans Bishop, Hyam Levitsky and Steve Harr.
How many employees does Juno Therapeutics have?
Juno Therapeutics has 282 employees.
What is Juno Therapeutics revenue?
Latest Juno Therapeutics annual revenue is $111.9 m.
What is Juno Therapeutics revenue per employee?
Latest Juno Therapeutics revenue per employee is $396.7 k.
Who are Juno Therapeutics competitors?
Competitors of Juno Therapeutics include H3 Biomedicine, Immatics and Kite Pharma.
Where is Juno Therapeutics headquarters?
Juno Therapeutics headquarters is located at 400 Dexter Ave N #1200, Seattle.
Where are Juno Therapeutics offices?
Juno Therapeutics has offices in Seattle, Bothell, Brisbane, Göttingen and in 1 other location.
How many offices does Juno Therapeutics have?
Juno Therapeutics has 7 offices.
Receive alerts for 300+ data fields across thousands of companies